X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (55231) 55231
Newsletter (4137) 4137
Newspaper Article (1455) 1455
Magazine Article (162) 162
Book Chapter (137) 137
Book / eBook (63) 63
Dissertation (41) 41
Trade Publication Article (24) 24
Reference (15) 15
Book Review (12) 12
Conference Proceeding (10) 10
Web Resource (7) 7
Transcript (5) 5
Publication (4) 4
Government Document (3) 3
Journal / eJournal (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42532) 42532
science & technology (40237) 40237
life sciences & biomedicine (34684) 34684
aids/hiv (26614) 26614
hiv (21504) 21504
immunology (20484) 20484
female (18159) 18159
male (17631) 17631
animals (14601) 14601
adult (14421) 14421
infectious diseases (13859) 13859
human immunodeficiency virus--hiv (12846) 12846
virology (10662) 10662
hiv infections - immunology (10380) 10380
hiv-1 - immunology (9680) 9680
middle aged (9225) 9225
aids (8904) 8904
viruses (7908) 7908
infections (7896) 7896
research (7542) 7542
health aspects (7144) 7144
research article (6897) 6897
hiv infection (6749) 6749
human immunodeficiency virus (6585) 6585
mice (6440) 6440
virus diseases (5871) 5871
microbiology (5809) 5809
acquired immune deficiency syndrome--aids (5561) 5561
science & technology - other topics (5529) 5529
abridged index medicus (5488) 5488
multidisciplinary sciences (5447) 5447
hiv infections - virology (5135) 5135
antibodies (5108) 5108
medicine (4882) 4882
vaccines (4761) 4761
adolescent (4637) 4637
medical research (4507) 4507
molecular sequence data (4499) 4499
hiv-1 (4267) 4267
risk factors (4242) 4242
proteins (4106) 4106
enzyme-linked immunosorbent assay (3972) 3972
science (3944) 3944
hiv-1 - genetics (3905) 3905
hiv infections - complications (3887) 3887
t cells (3885) 3885
cd4-positive t-lymphocytes - immunology (3811) 3811
amino acid sequence (3736) 3736
analysis (3707) 3707
aids vaccines (3623) 3623
hiv infections - drug therapy (3531) 3531
antigens (3510) 3510
lymphocytes (3465) 3465
aged (3460) 3460
cell line (3435) 3435
hiv antibodies - immunology (3325) 3325
acquired immune deficiency syndrome (3247) 3247
cd8-positive t-lymphocytes - immunology (3217) 3217
acquired immunodeficiency syndrome - immunology (3180) 3180
medicine, research & experimental (3121) 3121
research & experimental medicine (3103) 3103
cells, cultured (3080) 3080
hiv antibodies - blood (3041) 3041
aids vaccines - immunology (2995) 2995
hiv infections - epidemiology (2968) 2968
t-lymphocytes - immunology (2871) 2871
hiv-1 - physiology (2862) 2862
hiv - immunology (2839) 2839
vaccination (2774) 2774
physiological aspects (2754) 2754
hiv envelope protein gp120 - immunology (2727) 2727
immune response (2711) 2711
hiv infections - prevention & control (2707) 2707
flow cytometry (2703) 2703
antibodies, viral - analysis (2675) 2675
cell biology (2640) 2640
immune system (2622) 2622
cd4 lymphocyte count (2619) 2619
viral load (2582) 2582
biochemistry & molecular biology (2569) 2569
young adult (2543) 2543
medicine, experimental (2541) 2541
child (2505) 2505
antiviral agents (2470) 2470
biology (2445) 2445
cd4 antigen (2418) 2418
mice, inbred balb c (2417) 2417
hiv infections - diagnosis (2398) 2398
neutralization tests (2346) 2346
lymphocytes t (2295) 2295
drug therapy (2280) 2280
lymphocyte activation (2270) 2270
studies (2269) 2269
immunoglobulins (2234) 2234
prevalence (2224) 2224
polymerase chain reaction (2215) 2215
antibodies, monoclonal - immunology (2188) 2188
immunization (2185) 2185
hiv patients (2165) 2165
care and treatment (2154) 2154
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UTL at Downsview - May be requested (3) 3
St. Michael's Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Searching (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Theses (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (59867) 59867
Japanese (396) 396
Spanish (306) 306
French (291) 291
German (282) 282
Russian (256) 256
Chinese (177) 177
Portuguese (167) 167
Italian (75) 75
Polish (46) 46
Dutch (41) 41
Norwegian (23) 23
Danish (20) 20
Turkish (17) 17
Hungarian (12) 12
Swedish (11) 11
Czech (9) 9
Romanian (9) 9
Serbian (7) 7
Croatian (3) 3
Finnish (3) 3
Bulgarian (1) 1
Hebrew (1) 1
Korean (1) 1
Latin (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 0028-0836, 08/2014, Volume 514, Issue 7524, pp. 642 - 645
To protect against human immunodeficiency virus (HIV-1) infection, broadly neutralizing antibodies (bnAbs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | HIV Antibodies - blood | Antibodies, Neutralizing - analysis | HIV Infections - prevention & control | Immunity, Mucosal - immunology | Antibody-Dependent Cell Cytotoxicity - immunology | Half-Life | Administration, Rectal | Antibody Affinity - immunology | Male | HIV - immunology | Macaca mulatta | Antibodies, Viral - blood | Receptors, IgG - metabolism | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Antibodies, Viral - analysis | HIV - chemistry | Intestinal Mucosa - immunology | Female | Transcytosis | Simian Immunodeficiency Virus - immunology | HIV Antibodies - analysis | Mutagenesis, Site-Directed | Histocompatibility Antigens Class I - immunology | Antibody Affinity - genetics | Antibodies, Neutralizing - genetics | Binding Sites - genetics | Receptors, IgG - immunology | Rectum - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Receptors, Fc - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Immunization, Passive | Antibodies, Viral - immunology | HIV Envelope Protein gp160 - immunology | Mice | HIV Antibodies - genetics | Antibodies, Neutralizing - blood | Antibodies, Viral - genetics | CD4 Antigens - metabolism | Viral antibodies | Infection | Prevention | Fc receptors | Protein research | Antibodies | Primates | Research | Simian immunodeficiency virus | Health aspects | T cell receptors | Physiology | Mutation | Human immunodeficiency virus--HIV | Viral infections | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 09/2018, Volume 561, Issue 7724, pp. 479 - 484
.... Here we report on a phase 1b clinical trial in which a combination of 3BNC117 and 10-1074, two potent monoclonal anti-HIV-1 broadly neutralizing antibodies that target independent sites on the HIV-1... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Drug Resistance, Viral | Antibodies, Monoclonal - therapeutic use | Male | Phylogeny | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | HIV-1 - isolation & purification | Antibodies, Neutralizing - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Antibodies, Monoclonal - immunology | Carrier State - immunology | HIV Infections - virology | Viremia - drug therapy | HIV Antibodies - administration & dosage | Carrier State - virology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | Viremia - prevention & control | Adolescent | Carrier State - drug therapy | HIV Infections - drug therapy | Viremia - immunology | Aged | HIV Envelope Protein gp160 - immunology | Infusions, Intravenous | Binding Sites, Antibody | Virus Activation - immunology | Virus Latency - immunology | Anti-HIV Agents - immunology | Drug Combinations | Physiological aspects | HIV patients | Care and treatment | Drug therapy, Combination | HIV antibodies | Antiretroviral drugs | Therapy | Antiviral agents | Interruption | Immunoglobulins | Viremia | Clinical trials | Viruses | Infections | Genomes | Antiretroviral therapy | Antiretroviral agents | Lymphocytes | Human immunodeficiency virus--HIV | Monoclonal antibodies | Drug therapy | Bioinformatics | Binding sites | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 09/2014, Volume 515, Issue 7525, pp. 138 - 142
The isolation of human monoclonal antibodies is providing important insights into the specificities that underlie broad neutralization of HIV-1 (reviewed in ref. 1... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immunoglobulin Fab Fragments - ultrastructure | Antibody Specificity | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Leukocytes, Mononuclear | HIV Envelope Protein gp41 - chemistry | Virus Internalization - drug effects | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | Conserved Sequence | Inhibitory Concentration 50 | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Cell Line | Immunoglobulin Fab Fragments - genetics | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Models, Molecular | Antibodies, Neutralizing - pharmacology | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Monoclonal - genetics | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Cell Membrane - virology | Epitopes - chemistry | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Genetic aspects | Research | HIV infection | Antigenic determinants | Amino acids | Mutation | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 03/2014, Volume 509, Issue 7498, pp. 55 - 62
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the HIV-1 envelope, but the mechanism of their elicitation has been unclear... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Complementarity Determining Regions - genetics | Epitope Mapping | Epitopes, B-Lymphocyte - chemistry | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Antibody Affinity - immunology | Neutralization Tests | Epitopes, B-Lymphocyte - immunology | HIV Antibodies - isolation & purification | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Complementarity Determining Regions - chemistry | HIV-1 - chemistry | Binding Sites - immunology | B-Lymphocytes - metabolism | Protein Structure, Tertiary | Amino Acid Sequence | CD4 Antigens - immunology | B-Lymphocytes - cytology | Models, Molecular | Antibody Affinity - genetics | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Neutralizing - isolation & purification | Cell Lineage | HIV-1 - immunology | B-Lymphocytes - immunology | Antibodies, Neutralizing - chemistry | Complementarity Determining Regions - immunology | HIV Envelope Protein gp160 - immunology | HIV Antibodies - genetics | Somatic Hypermutation, Immunoglobulin - genetics | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Antigen-antibody reactions | AIDS vaccines | AIDS (Disease) | Antibodies | Physiological aspects | Research | AIDS research | Cell culture | Genes | Human immunodeficiency virus--HIV | Phylogenetics | Amino acids | Infections | Genomes | Mutation | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 10/2011, Volume 334, Issue 6059, pp. 1097 - 1103
The HIV envelope (Env) protein gpl20 is protected from antibody recognition by a dense glycan shield... 
Polysaccharides | HIV | Neutralizing antibodies | RESEARCH ARTICLES | Antibodies | Viruses | Trimers | Epitopes | Grants | Binding sites | Crystal structure | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibody Specificity | Mannose - immunology | Disaccharides - metabolism | Humans | Antibodies, Neutralizing - metabolism | Crystallography, X-Ray | Disaccharides - chemistry | Mannosides - chemistry | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Mannose - metabolism | Antibodies, Neutralizing - immunology | HIV-1 - physiology | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Oligosaccharides - chemistry | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Mannose - chemistry | HIV Antibodies - metabolism | Protein Structure, Tertiary | Cell Line | Models, Molecular | Antibodies, Neutralizing - genetics | Glycosylation | Polysaccharides - immunology | Oligosaccharides - metabolism | HIV Antibodies - chemistry | Polysaccharides - metabolism | HIV-1 - immunology | Hydrogen Bonding | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Oligosaccharides - immunology | Protein Conformation | Mannosides - metabolism | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | Mutation | Binding Sites, Antibody | Carbohydrate Conformation | Viral antibodies | Physiological aspects | Development and progression | Glycoproteins | HIV (Viruses) | Health aspects | Proteins | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 11/2011, Volume 480, Issue 7377, pp. 336 - 343
Journal Article